T-Cell Response to Vaccination | Clinical Research Studies Listing

Recruiting

18 years - 65 years

All

Phase N/A

1 Location

Brief description of study

The purpose of this study is to see how your body responds to a vaccine and how your body forms a protective response after vaccination. In this study we will use the yellow fever vaccine, an FDA approved vaccine that is commonly given to people traveling to certain parts of Africa and South America.

Detailed description of study

The study consists of a screening visit followed by 9 study visits. From the time of screening, you will be in this study for between 8-12 months. The study include: Screening visit (approx 1 hour), Study visit 1 - Luekopheresis (approx 2.5 hours), Study Visit 2 - Vaccination (approx 45 mins), Study Visits 3-8 - Blood Draws (approx 30 mins), Study Visit 9 - Leukopheresis (approx 2.5 hours).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: healthy Volunteers,healthy subjects,Healthy,Healthy volunteer,healthy,healthy volunteer,healthy volunteers,healthy subjects,healthy
Age: 18 years - 65 years
Gender: All

Updated on 19 Feb 2024. Study ID: 820884

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).